Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thiamine Supplementation in Septic Shock
NCT03122678Phase 1Withdrawn
- Sponsor
- Cleveland Clinic
- Start
- Nov 2016
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in septic shock comparing Thiamine Group with Placebo Group (2 arms). Primary endpoints: Time to Reversal of Shock at 7 days and Time to Normalization of Lactic Acidosis at 7 days. Planned start Nov 2016; status: withdrawn.
02
Drugs
thiamine
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT03122678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03122678.